News | April 29, 2022
Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar
The plant is expected to start commercial operations from Q4FY24
The plant is expected to start commercial operations from Q4FY24
The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
This facility will design & develop instruments, perform product reliability performance testing and verification
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
Food-tech disruptor prepares to vastly scale dairy-identical, non-animal milk protein production in a pioneering sustainable industrial park in Denmark
A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme
Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'
Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region
Subscribe To Our Newsletter & Stay Updated
